The link apparently did not copy correctly the fir
Post# of 148294
This should be the correct link.
http://www.kleinstocklaw.com/pslra-1/cytodyn-...amp;from=1
Other sources allege this -
Quote:
The complaint, filed on March 17, 2021, alleges that defendants violated provisions of the Exchange Act by making false and misleading statements concerning leronlimab being used as a treatment for COVID-19.
What would those statements be? By the time this lawsuit is adjucated in a courtroom (if it ever does) the longhaulers phase 2, CD16 and CD17 trials should be finished. What are the plaintiff's lawyers going to argue "they said it would work with COVID and it does".